Recent News

  • Researchers develop easy and effective therapy to restore sight -   To evolve the virus best suited for gene therapy, Berkeley researchers created more than 100 million engineered adeno-associated viruses (left) and injected them into the gel-like center of the eye. Those able to penetrate the many cell layers of the retina are used to shuttle a corrective gene into cells with a defective gene. [...]
  • Experimental Ebola drug cured 100% of monkeys tested -   In what scientists are calling a “monumental achievement,” an experimental medication called ZMapp — given on a compassionate basis to a handful of Ebola victims in the current outbreak — cured 100% of monkeys treated in a Canadian study, researchers announced Friday. ZMapp, made by Mapp Biopharmaceuticals of San Diego, is in the early [...]
  • 2015 Meeting Attendance - Pristima Suite Is Key To Frontier’s Goal of Becoming Preeminent Preclinical Service Provider
  • Expertise

    Frontier BioSciences, Inc. is a leading global contract research organization (CRO) providing drug discovery, development, and regulatory guidance in China.  Our clients and partners include biotechnology, pharmaceutical, medical device, academic, and government organizations.  With toxicology laboratories in Chengdu and Kunming in China and partnership with West China (Huaxi) Hospital, Frontier applies international CRO experience, therapeutic expertise, and commitment to quality to assist our clients and partners in delivering their drugs to market.


    Why Frontier BioSciences, Inc.?

    • Staff with international CRO & big pharma experience
    •  Staff members on the SFDA IND/NDA review board
    •  AAALAC International-accredited
    •  Contracts with U.S. government agencies (DoD, DHHS/NIAID/BARDA)
    •  Most comprehensive NHP historical database in China
    •  Partnership with West China (Huaxi) Hospital, largest hospital in Asia
    •  U.S. FDA accepted data

    Contact us to learn more.